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In humans, paralytic poliomyelitis results from the invasion of the central nervous system
(CNS) by circulating poliovirus (PV) via the blood–brain barrier (BBB). After the virus enters
the CNS, it replicates in neurons, especially in motor neurons, inducing the cell death that
causes paralytic poliomyelitis. Along with this route of dissemination, neural pathway has
been reported in humans, monkeys, and PV-sensitive human PV receptor (hPVR/CD155)-
transgenic (Tg) mice. We demonstrated that a fast retrograde axonal transport process is
required for PV dissemination through the sciatic nerve of hPVR-Tg mice and that intramus-
cularly inoculated PV causes paralysis in a hPVR-dependent manner.We also showed that
hPVR-independent axonal transport of PV exists in hPVR-Tg and non-Tg mice, indicating
that several different pathways for PV axonal transport exist in these mice. Circulating PV
after intravenous inoculation in mice cross the BBB at a high rate in a hPVR-independent
manner. We will implicate an involvement of a new possible receptor for PV to permeate
the BBB based on our recent ﬁndings.
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INTRODUCTION
Poliovirus (PV), known to be the causative agent of poliomyeli-
tis, is a human enterovirus that belongs to the Picornaviridae.
After oral ingestion of PV in humans, the virus may suffer the
low pH in stomach to decrease its viability (Ohka etal., 2007;
Figure 1). Then, the virus multiplies in the alimentary mucosa
(Bodian, 1955; Sabin, 1956), and moves into the bloodstream.
The circulating virus invades the central nervous system (CNS)
and replicates in motor neurons (MNs). Paralytic poliomyelitis
occurs as a result from destruction of MNs by PV replication. In
terms of routes for PV dissemination,there are three main routes;
transmission from the alimentary mucosa to blood (Figure 1A;
Bodian, 1955; Sabin, 1956), permeation through the blood–brain
barrier (BBB) into brain (Figure 1B;Yang etal., 1997), and trans-
mission via peripheral MNs from muscle into brain (Figure 1C;
Howe and Bodian, 1942; Nathanson and Langmuir, 1963; Ren
and Racaniello, 1992b; Ohka etal., 1998). The species speciﬁcity
of this virus is governed by a speciﬁc cell surface molecule that
serves as the PV receptor (PVR). Indeed, transgenic (Tg) mice
carrying the human PVR (hPVR/CD155) gene show susceptibil-
ity to PV, although mice are generally not susceptible to the virus
(Ren etal., 1990; Koike etal., 1991). Tg mice are susceptible to
PV when the mice are infected via intravenous and intramuscular
routes but not via oral routes (Ren etal., 1990; Koike etal., 1991,
1994a,b;RenandRacaniello,1992a,b;Horieetal.,1994;Zhangand
Racaniello, 1997). The Tg mice became susceptible to oral infec-
tion when interferon (IFN)-α/β receptor gene is disrupted (Ohka
etal.,2007). The two dissemination routes through BBB and MNs
are also functional in PV-sensitive Tg mice, whereas the routes
through alimentary mucosa is not functional in PV-sensitive Tg
mice with normal IFN-α/β response.
PVR-DEPENDENT AND -INDEPENDENT RETROGRADE
AXONAL TRANSPORT FROM MUSCLE TO CNS
Axonaltransportisacellularprocessresponsibleformovementof
mitochondria, lipids, synaptic vesicles, proteins, and organelles to
and from a neuron’s cell body, through the cytoplasm of its axon.
It is well known that some viruses, such as Rabies virus, hijacks
the retrograde axonal transport, i.e., from synapse to cell body, to
invade the CNS (Warrell and Warrell, 2004). Using a PV-sensitive
Tg mouse line, we have shown that intramuscularly inoculated
PV is taken up by endocytosis at synapses (Figure1C; Ohka etal.,
2004). PV is able to invade the CNS by traveling on this cargo.
The vesicles containing intact PV particles are transported retro-
gradely along with the axon without initiating uncoating (Ohka
etal.,1998). Theuncoatingeventtakesplaceatthecellbodyof the
MN.Wedemonstratedthatafastretrogradeaxonaltransportpro-
cess is required for PV dissemination through the sciatic nerve of
hPVR-TgmiceandthatintramuscularlyinoculatedPVcausespar-
alyticdiseaseinahPVR-dependentmanner(Ohkaetal.,1998).We
alsoshowedthathPVR-independentaxonaltransportof PVexists
in hPVR-Tg and non-Tg mice, indicating that several different
pathways for PV axonal transport exist in these mice (Ohka etal.,
2009). The velocity of hPVR-independent axonal transport of PV
(∼0.5 μm/s) is slower than hPVR-dependent axonal transport
(>0.5 to ∼3.7 μm/s) in vivo. Using primary MNs isolated from
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FIGURE 1 | Dissemination pathway for PV in human. Oral ingested PV invades into blood through alimentary tract (A) followed by viremia.The virus in the
blood permeates BBB into CNS (B). PV also invades into CNS directly by neural pathway through MNs from skeletal muscle to CNS (C).
these mice or rats, we demonstrated that the axonal transport of
PV requires several kinetically different motor machineries (Ohka
etal., 2009). The fast speed component was ≥1.4 μm/s, whereas
theslowcomponentwascenteredbetween0.4and1.0μm/s.Using
a mutant hPVR, that has a lower afﬁnity to cytoplasmic dynein
than intact hPVR, we revealed that the fast transport relies on a
system involving cytoplasmic dynein (Ohka etal.,2004).
AXONAL TRANSPORT OF PV IN VIVO AND IN
CULTURED MNs
Unexpectedly, the hPVR-independent incorporation of PV fol-
lowed by the axonal transport was not observed in cultured MNs.
Thus, PV transport machineries in cultured MNs and in vivo
differ in their hPVR requirements (Ohka etal., 2009). Figure 2
summarizes the PV transports depending on the cell types. In
hPVR-Tg mice, most of the hPVR-containing vesicles are ret-
rogradely transported with fast kinetics in an hPVR-dependent
manner. PV is also transported in a hPVR-independent man-
ner with slow kinetics by an unknown mechanism. Indeed, PV
istransportedwithslowkineticsinnon-Tgmice. InisolatedMNs,
onlyhPVR-dependentPVendocytosisisdetected. Noendocytosis
of PV is detected in control cultured MNs lacking hPVR. These
results suggest that the axonal trafﬁcking of PV is carried out by
several distinct pathways, and that MNs in culture and in the sci-
atic nerve in vivo are fundamentally different in the uptake and
axonal transport of PV.
For elucidating the precise mechanisms of infection in MNs,
it is important to establish a culture system closely mimicking
in vivo. MNs in culture and in the sciatic nerve in vivo are differ-
ent in the uptake and axonal transport of PV (Ohka etal., 2009).
The differences might be due to the lack of neuromuscular junc-
tions in MNs in culture. Furthermore, MNs are infected both at
synapse side and cell body side in conventional culture system,
whereas the natural infection occurs mainly at the synapse side
in vivo. To reﬂect the conditions in vivo, we applied microﬂu-
idic culture platform made of polydimethylsiloxane (PDMS) that
polarizes the growth of neural axons ﬂuidically isolated environ-
ment(Tayloretal.,2005;Parketal.,2006),whichenablesinfection
withPVonlyfromsynapsesideorcellbodyside.Usingthesystem,
we indicated that the infection from the synapse side intrinsically
differ from the infection from the cell body side (author’s unpub-
lished data). This system may enable co-culture of the synapse
side of MNs with muscular cells to form neuromuscular junc-
tions,which more closely mimic in vivo,and will shed light on the
preciseanalysisof earlyinfection withinfectiousagentsinMNsin
culture.
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FIGURE 2 | Mechanisms for hPVR-dependent and -independent
transport of PV in MNs. (A) In hPVR-Tg mice, PV is endocytosed after
interacting to hPVR (Aa). Most of the hPVR-containing vesicles are
retrogradely transported in an hPVR-dependent manner with fast kinetics
(Ac). hPVR-independent endocytosis (Ab) and transport (Ae) of PV also
occur.The hPVR-independent endocytosis is possibly mediated by an
unidentiﬁed PV receptor expressed at neuromuscular junctions. Alternatively,
hPVR-independent endocytosis may be promoted by synaptic activity
in vivo. PV-containing vesicles with or without hPVR can be retrogradely
transported in an hPVR-independent manner with slow kinetics
(Ad andAe). (B) In non-Tg mice, PV is endocytosed and transported with
slow kinetics in an hPVR-independent manner (Be).The hPVR-independent
endocytosis is possibly mediated by the unidentiﬁed PV receptor expressed
at neuromuscular junctions (Bb). (C) In cultured MNs, only hPVR-dependent
PV endocytosis is detected (Ca).The hPVR-dependent transport shows
fast kinetics (Cc). It might be possible that the slow component in
cultured MNs (Cd) requires hPVR for endocytosis, whereas its transport
may be hPVR-independent. (D) No endocytosis of PV is detected in
cultured MNs lacking hPVR, possibly due to the absence of the
unidentiﬁed PV receptor.
TRANSFERRIN RECEPTOR-DEPENDENT BBB PERMEATION
Vascularendothelialcellsmakeupthewallsthataresealedtogether
attheiredgesbytightjunctions.BBBdoesnotallowthefreetrans-
portation of materials including pathogens between the blood-
stream and parenchyma of the CNS and blocks viral infection in
the CNS. Evidences that support PV invasion of BBB by infecting
endothelial cells in vivo have not been reported. PV is believed to
invade the CNS through the BBB. PV permeation through BBB
is hPVR-independent and fast as cationized rat serum albumin
which is known to permeate the BBB at a high rate (Yang etal.,
1997). Similarly, using transwell in vitro BBB model involving
mouse brain capillary endothelial cells (MBEC4), we demon-
strated that BBB permeation of PV is hPVR-independent and fast
as that of transferrin (Figure3,author’s unpublished data). These
evidences strongly suggest the presence of a new PV receptor for
BBBpermeation.ToelucidatethenewPVreceptorwhichinteracts
withPV,weanalyzedthePV-interactingproteinbymassspectrom-
etry.Asaresult,weidentiﬁedmousetransferrinreceptor1(TfR1),
a membrane bound receptor for transferrin, as a binding protein
to PV. Furthermore, peptide sequences of mouse TfR1 and PV
involvedinthebindingwereidentiﬁed(author’sunpublisheddata;
the data will be published on another paper). The identiﬁed pep-
tide of PV had a permeation activity in in vitro BBB model using
MBEC4 cells cultured in transwell,and the permeation was fast as
transferrin (Figure 3). Therefore, mouse TfR1 is a possible recep-
tor of PV for the BBB permeation. As for the homology of TfR1
between mouse and human, both mouse TfR1 and human TfR1
conservefunctionof irondeliveryandthebindingsiteof TfR1has
higher sequence homology (89%) between human and mouse
TfR1 than the full length TfR1 molecule (77%). The homology
indicates that human TfR1 may function as a PV receptor for the
BBB permeation in natural infection in human.
Surprisingly, the majority of the PV related materials after the
BBB permeation were intact infectious particles in the brain of
hPVR-Tg mice and non-Tg mice (Yang etal., 1997). Moreover,
the permeated materials contained infectious particles in in vitro
BBB model (author’s unpublished data). These evidences indi-
cate that PV retains infectivity during the BBB permeation, the
transcytosis through capillary endothelial cell layers. At present,it
cannot be excluded that TfR1 could actually be the long sought
after molecule involved in the hPVR-independent axonal trans-
port of PV in vivo. TfR1 is expressed in MNs in mouse spinal cord
(Jeong etal., 2011), supporting the hypothesis that TfR1 exists in
MNs of sciatic nerve and serves to facilitate hPVR-independent
axonal transport. MNs extending neurite in culture express only
a small amount of TfR1 (Nakamura etal., 2011), which is consis-
tent with the lack of PV incorporation into MNs in culture (Ohka
etal.,2009).
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FIGURE 3 | Models for BBB permeation of PV.TfR1 attaches to PV (A), transferrin (B), or PV peptide (C) and transported through brain capillary endothelial
cells into brain by a fast process. On the other hand, dextran (MW > 15 K) is not transcytosed byTfR1 and leaks between cell junctions by a slow process (D).
DISSEMINATION THROUGH ALIMENTARY MUCOSA
The mechanism of the dissemination through alimentary mucosa
is unclear (Figure 1A). The instability of the virus in the gastric
environment decreases the efﬁciency of the oral infection in mice
(Ohka etal., 2001). Furthermore, we have shown that IFN-α/β
plays an essential role in preventing PV from replicating in the
intestines using hPVR-Tg mice with or without IFN-α/β recep-
tor expression (Ohka etal., 2001). Recently, Kuss etal. (2011)
reported that intestinal bacteria promote PV replication and sys-
temicpathogenesisusinghPVR-TgmicewithoutIFN-α/βreceptor
expression, indicating that intestinal microbes may enhance PV
intestinal infection even in human. In terms of the receptor
localization in polarized epithelial cells, hPVRα, one of the two
identiﬁed membrane bound forms of hPVR, shows basolateral
localization due to its basolateral sorting signal, whereas hPVRδ,
another membrane bound form of hPVR,non-polarized localiza-
tion (Ohka etal., 2001). hPVRs mainly localizes to the basolateral
in human colon carcinoma (Caco-2) epithelia cells (Ohka etal.,
2001) and human Peyer’s patches including human microfold
cells (M cells), that are distinctive mucosal epithelial cells medi-
ating immune surveillance (Iwasaki etal.,2002). Nevertheless,PV
efﬁciently permeates alimentary mucosa from the apical side into
bloodstream,suggestingthepossibilitythatasmallamountofapi-
cal hPVR or another PV receptor besides hPVR contributes to the
transport. It should be noted that PV does not replicate in the ali-
mentary tracts of hPVR-Tg mice that express high levels of hPVR
in the intestinal epithelial cells after oral administration (Zhang
andRacaniello,1997)incontrasttoitsbehaviorinhumans. Much
work should be done to elucidate mechanisms of PV infection in
and dissemination from the alimentary tract.
CONCLUSION
We demonstrated that axonal transport of PV includes hPVR-
dependent and -independent pathways,implying the involvement
of a new receptor for PV besides hPVR. We also demonstrated
that PV permeates BBB at a high rate in an hPVR-independent
manner, and we implicated a new possible receptor for PV to
permeate the BBB. Thus, PV receptors including hPVR and new
possible receptors play important roles for PV dissemination. It
is important to elucidate new possible receptors in the future to
clarify the precise mechanisms for PV dissemination pathways.
Additionally, we revealed that the discrepancy exists between in
vivoand in cultured MNs. It would be useful to establish adequate
systemsincultureforelucidatingthetransportmechanismsof PV.
The discrepancy itself might be a clue for understanding the event
in vivo.
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